Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 3, 2026

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

PPAR-gamma: Therapeutic Potential for Multiple Sclerosis.

Paul D Drew1, Jihong Xu, Michael K Racke

  • 1Department of Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences, Biomedical Research Building II, Room 563-2, 4301 W. Markham Street, Little Rock, AR 72205, USA.

PPAR Research
|July 8, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular characterization and whole-genome sequencing-based genetic evolution of coxsackievirus A16 in Taiyuan City, 2023-2025.

Archives of virology·2026
Same author

DFB laser arrays utilizing CPM-based sampled gratings for precise wavelength control and enhanced single-mode stability.

Optics express·2026
Same author

Atomic-Level Composition Engineering in M<sub>25</sub> Nanoclusters for Photocatalytic Degradation of Methylene Blue: From Homometallic Au<sub>25</sub>, Ag<sub>25</sub>, and Cu<sub>25</sub> to Heterometallic Au<sub>1</sub>Cu<sub>24</sub>.

The journal of physical chemistry. A·2026
Same author

Trends, disparities, and socioeconomic inequalities in periconceptional folic acid supplementation in China: a nationwide survey analysis.

BMC pregnancy and childbirth·2026
Same author

Husbands' smoking and risk of diabetes in reproductive-aged Chinese women: a nationwide population-based cohort study.

BMC public health·2026
Same author

An Impact Load History Reconstruction Method for Composite Structures Based on FBG Sensing Data and the GCV Principle.

Sensors (Basel, Switzerland)·2026
Same journal

Correction to "Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?"

PPAR research·2026
Same journal

Latest Advances in Obesity Treatment by Regulating Adipocyte Thermogenesis.

PPAR research·2026
Same journal

Metabolic Reprogramming and Immune Metabolism in Sepsis: Targeting the PPAR Pathway for Personalized Therapeutic Approaches.

PPAR research·2026
Same journal

Mediating Role of Muscle Mass in the Relationship Between Physical Activity and Bone Mass in Female University Students in China.

PPAR research·2026
Same journal

Correction to "Pemafibrate Pretreatment Attenuates Apoptosis and Autophagy During Hepatic Ischemia-Reperfusion Injury by Modulating JAK2/STAT3<i>β</i>/PPAR<i>α</i> Pathway".

PPAR research·2026
Same journal

The Mechanistic Role of PPAR<i>γ</i> in Wound Healing.

PPAR research·2026
See all related articles

Peroxisome proliferator-activated receptors (PPARs) influence immune responses. PPAR-gamma agonists show potential in treating multiple sclerosis by modulating experimental autoimmune encephalomyelitis.

Area of Science:

  • Immunology and Metabolism
  • Neuroscience

Background:

  • Peroxisome proliferator-activated receptors (PPARs) are known regulators of lipid and glucose metabolism.
  • Emerging research highlights their significant role in modulating immune system functions.
  • Previous studies have shown that PPAR-gamma agonists impact experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS).

Purpose of the Study:

  • To review the cellular and molecular mechanisms underlying PPAR-gamma agonist effects in EAE.
  • To explore the therapeutic potential of PPAR-gamma agonists for multiple sclerosis treatment.

Main Methods:

  • Literature review of studies on PPARs, EAE, and multiple sclerosis.
  • Analysis of cellular and molecular pathways involved in PPAR-mediated immune modulation.

Related Experiment Videos

Last Updated: Jul 3, 2026

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

Main Results:

  • PPAR-gamma agonists have demonstrated a capacity to modulate the progression of experimental autoimmune encephalomyelitis.
  • Understanding the mechanisms of action provides insights into immune regulation.

Conclusions:

  • PPAR-gamma agonists represent a promising therapeutic avenue for multiple sclerosis.
  • Further research into the specific mechanisms could optimize treatment strategies for autoimmune diseases.